Address And Details

500 Boylston St , Boston, MA 02116
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The fund s investment objective is to seek total return. MFS (Massachusetts Financial Services Company, the fund s investment adviser) invests the fund s assets in equity securities and debt instruments. Equity securities include common stocks and other securities that represent an ownership interest (or right to acquire an ownership interest) in a company or other issuer. Debt instruments include corporate bonds, foreign government securities, U.S. Government securities, securitized instruments, and other obligations to repay money borrowed. MFS generally invests approximately 60% of the fund s assets in equity securities and approximately 40% of the fund s assets in debt instruments. These weightings do not reflect the fund s cash balance and can vary over time due to market movements and cash flows. Of the fund s investments in equity securities, MFS focuses on investing the fund s assets in the stocks of companies it believes are undervalued compared to their perceived worth (value companies). MFS normally invests a portion of the fund s assets in income-producing equity securities. While MFS may invest the equity portion of the fund s assets in securities of companies of any size, MFS primarily invests in securities of companies with large capitalizations. MFS invests the fund s assets in U.S. and foreign securities, including emerging market securities. MFS normally invests the fund s assets across different industries, sectors, countries, and regions, but MFS may invest a significant percentage of the fund s assets in issuers in a single industry, sector, country, or region. MFS generally invests the fund s assets in at least three different countries and invests a percentage of the fund s net assets in securities of foreign issuers equal to at least the lesser of 40% or the percentage of foreign issuers in the MSCI World Index (the Index) less 15%. Of the fund s investments in debt instruments, MFS generally invests substantially all of these investments in investment grade quality debt instruments. While MFS may use derivatives for any investment purpose, to the extent MFS uses derivatives, MFS expects to use derivatives primarily to increase or decrease exposure to a particular market, segment of the market, or security, to increase or decrease interest rate or currency exposure, or as alternatives to direct investments. Derivatives include futures, forward contracts, options, swaps, and certain complex structured securities. MFS uses an active bottom-up investment approach to buying and selling investments for the fund. Investments are selected primarily based on fundamental analysis of individual issuers and instruments. For a segment of the equity portion of the fund, investments are selected primarily based on blending fundamental and quantitative research. Quantitative models that systematically evaluate issuers and instruments are used by certain of the fund s equity securities portfolio managers and may also be considered by the fund s other portfolio managers.

Net Asset Value

as of 5:47 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.74%
  • 1 Month
  • -1.14%
  • 3 Months
  • +0.30%
  • 1 Yr Return
  • +7.46%
  • 5 Yr Return
  • +19.95%

Equity Sector Breakdown

Finance 12.27%
Technology 8.45%
IndustrialCyclical 7.64%
NonDurables 6.70%
Health 4.19%
Services 3.72%
ConsumerDurables 3.40%
Utilities 2.07%
RetailTrade 1.80%
Energy 0.90%

Asset Allocation

Asset Type % Of Allocation
Stocks 58.70%
ForeignStocks 27.91%
Preferred 0.50%
Convertible 0.22%
Cash 0.00%
Bonds 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 126.54 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -2.05 -3.25 -2.67
Beta 0.56 0.55 0.57
R Squared 0.90 0.83 0.83
Std Deviation 10.98 9.13 8.41
Sharpe Ratio 0.72 0.67 n/a

Purchase Information

as of 5:44 PM ET 09/16/2021
Minimum Initial $1000
Minimum Additional $50
Minimum Initial IRA $250

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +16.21%
  • +20.56%
+16.21% +20.56%
3 Year
  • +8.43%
  • +8.57%
+8.43% +8.57%
10 Year
  • +6.60%
  • +6.10%
+6.60% +6.10%
Life Of Fund
  • +6.79%
  • +6.76%
+6.79% +6.76%

Top 10 Holdings

Symbol Company Name % Of Assets
V2853 SCHNEIDER SA 1.48%
ROG ROCHE HOLDING AG 1.45%
JNJ JOHNSON & JOHNSON 1.23%
TSM TAIWAN SEMICONDUCTOR MANUFACT 1.19%
9433.T KDDI CORP 1.17%
ETN EATON CORP PLC 1.06%
AON AON PLC 0.97%
JPM JPMORGAN CHASE & CO 0.95%
UBS UBS GROUP AG 0.95%
CMCSA COMCAST CORP 0.92%

Recent Articles from TheStreet

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

The drop could come as fiscal stimulus is withdrawn and economic growth slows, he says. Earnings revisions also may pose a problem.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.